Aids Day Treatment Program New York City, NY - 10011

Aids Day Treatment Program is categorized under Aids Information and Testing in New York City, NY .

Aids Day Treatment Program was established in 0, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Aids Information and Testing business, which does work in the B2C market, and is classified as a Aids Information and Testing, under code number 6219990 by the NAICS.

If you are seeking more information, feel free to contact Michael Hickey, Director at the company’s single location by writing to 121b West 20th St, New York City, New York NY 10011 or by phoning (212) 337-9220. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Aids Day Treatment Program
Contact Person: Michael Hickey, Director
Address: 121b West 20th St, New York City, New York 10011
Phone Number: (212) 337-9220
Annual Revenue (USD): $2.500.000 to $4.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Aids Information and Testing
SIC Code: 8099
NAICS Code: 6219990
Share This Business:

Aids Day Treatment Program was started in 0 to provide professional Aids Information and Testing under the SIC code 8099 and NAICS code 6219990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Michael Hickey, Director for inquiries that concern Aids Day Treatment Program by calling the company number (212) 337-9220, as your correspondence is most welcome. Additionally, the physical location of the single location of Aids Day Treatment Program can be found at the coordinates 40.74162,-73.99558 as well as the street address 121b West 20th St in New York City, New York 10011.

For its online presence, you may visit Aids Day Treatment Program’s website at and engage with its social media outlets through on Twitter and on Facebook.